Clinical analysis and pluripotent stem cells-based model reveal possible impacts of ACE2 and lung progenitor cells on infants vulnerable to COVID-19.
Zhang Z, Guo L, Lu X, Zhang C, Huang L, Wang X, Duan F, Liang H, Chen P, Zeng L, Shao J, Li H, Li L, Liu L, Li C, Zhang J, Ma CY, Kwan KY, Liu W, Xu Y, Gu X, Jiang H, Du H, Zhang T, Wu Y, Yu G, Chen J, Luo R, Liao C, Tse HF, Chen Z, Chen HJ, Xia H, Lian Q.
Zhang Z, et al. Among authors: chen j, chen z, chen p, chen hj.
Theranostics. 2021 Jan 1;11(5):2170-2181. doi: 10.7150/thno.53136. eCollection 2021.
Theranostics. 2021.
PMID: 33500718
Free PMC article.